-
Knicks forward Anunoby trains as NBA Eastern Conference finals loom
-
American McNealy grabs PGA lead at difficult Aronimink
-
Substitute 'keeper sends Saint-Etienne into promotion play-off
-
Sinner's bid to reach Italian Open final held up by Roman rain
-
Aston Villa humble Liverpool to secure Champions League qualification
-
US says Iran-backed militia commander planned Jewish site attacks
-
Bolivia unrest continues despite government deal with miners
-
Scheffler slams 'absurd' PGA pin locations
-
New deadly Ebola outbreak hits DR Congo, 1 dead in Uganda
-
Democrats accuse Trump of stock trade corruption
-
'Beyond the Oscar': Travolta gets surprise Cannes prize
-
Israel, Lebanon say extending ceasefire despite new strikes
-
Potgieter grabs early PGA lead at difficult Aronimink
-
Prosecutors seek death penalty for US man charged with killing Israeli embassy staffers
-
Judge declares mistrial in Weinstein sex assault case
-
Canada takes key step towards new oil pipeline
-
Iranian filmmaker Farhadi condemns Middle East war, protest massacres
-
'Better than the Oscar': John Travolta gets surprise Cannes prize
-
Marsh muscle motors Lucknow to victory over Chennai
-
Judge declares mistrial in Weinstein case as jury fails to reach verdict
-
Eurovision finalists tune up as boycotting Spain digs in
-
Indonesia's first giant panda is set to charm the public
-
Cheer and tears as African refugee rap film 'Congo Boy' charms Cannes
-
Norwegian Ruud rolls into Italian Open final, Sinner set for Medvedev clash
-
Bolivia government says deal reached with protesting miners
-
Showdowns and spycraft on Trump-Xi summit sidelines
-
Smalley seizes PGA lead with Matsuyama making a charge
-
Acosta quickest in practice for Catalan MotoGP
-
Nuno wants VAR 'consistency' as West Ham fight to avoid relegation
-
Vingegaard powers to maiden Giro stage victory
-
Iran to hold pre-World Cup training camp in Turkey: media
-
US scraps deployment of 4,000 troops to Poland
-
Ukraine vows more strikes on Russia after attack on Kyiv kills 24
-
Bayern veteran Neuer signs one-year contract extension
-
Ukraine can down Russian drones en masse. But missiles are a problem
-
Israeli strikes wound dozens in Lebanon as talks in US enter second day
-
'Everybody wants Hearts to win', says Celtic's O'Neill ahead of title decider
-
Scheffler stumbles from share of lead at windy PGA
-
New deadly Ebola outbreak hits DR Congo
-
Farke calls for Leeds owners to match his ambition
-
Zverev pulls out of home event in Hamburg with back injury
-
Xi, Trump eke small wins from talks but no major deals: analysts
-
De Ligt to miss World Cup after back surgery
-
England's Rice braces for 'hate and love' at World Cup
-
Milan Fashion Week says will ask brands not to show fur
-
French-German tank maker KNDS to push ahead with IPO
-
Man City campaign a success regardless of trophies: Guardiola
-
'World's oldest dog' contender dies in France aged 30
-
No.1 Scheffler opens with bogey to fall from share of PGA lead
-
Carrick says Man Utd future to be decided 'pretty soon'
US announces new funds for mRNA vaccines, fast tracks bird flu tests
President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines against emerging biothreats and said it was accelerating bird flu testing, as fears loom of another pandemic.
In all, 67 people in the United States have been infected with avian influenza since the outbreak began last year, including an elderly man who died in Louisiana earlier this month.
While the virus has not conclusively been found to spread from person to person, the amount of bird flu circulating among animals and humans has alarmed scientists, because it might combine with seasonal influenza and mutate into a more transmissible form -- potentially triggering a deadly pandemic.
"This latest intended investment illustrates the Biden-Harris Administration's robust response to emerging disease threats such as avian influenza," said health secretary Xavier Becerra.
Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. This technology trains the body's immune system using genetic instructions, an approach proven highly effective against Covid. Moderna received $176 million for this effort in July 2024.
The United States also maintains a stockpile of millions of H5N1 vaccine doses based on traditional methods, targeting earlier virus strains but expected to offer solid protection if needed, experts say.
Meanwhile, the Centers for Disease Control and Prevention announced that all positive influenza A tests, especially from hospitalized patients, will be fast-tracked for further testing to check for H5N1.
"H5N1 is a subtype of influenza A," said Nirav Shah, a senior CDC official. Subtyping determines whether the virus is a common seasonal strain or a novel version like H5N1, he explained.
Such testing should ideally be completed within 24 hours, he added, to help researchers understand how the infection occurred, identify potential exposures, and protect health workers.
Until the Louisiana fatality, US cases had been relatively mild. Globally, however, nearly half of the 954 human H5N1 infections recorded since 2003 have been fatal, according to the World Health Organization.
Concerns have also been raised about incoming President Donald Trump's pick for health secretary, Robert F. Kennedy Jr., a vocal critic of vaccines, especially mRNA technology -- widely regarded as a key tool against future pandemics.
He is also a known fan of raw milk, which has repeatedly been found to be contaminated with bird flu from infected dairy cows.
I.Meyer--BTB